Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica El alto nivel de resistencia a los carbapenemes en Acinetobacter baumannii es un...
Información de la revista
Vol. 19. Núm. 7.
Páginas 336-338 (Agosto 2001)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 19. Núm. 7.
Páginas 336-338 (Agosto 2001)
Acceso a texto completo
El alto nivel de resistencia a los carbapenemes en Acinetobacter baumannii es un problema multifactorial
Visitas
6105
Germán Bou1
Autor para correspondencia
bou.german@mayo.edu

Correspondencia: Dr G. Bou. Laboratory of Viral Immunology. Division of Infectious Diseases. Mayo Clinic. 200 First Street SW. Guggenheim 516. Rochester. MN 55905
Laboratory of Viral Immunology. Division of Infectious Diseases. Mayo Clinic. Rochester. USA
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
E. Bergogne-Bérézin, K.J. Towner.
Acinetobacter spp. as nosocomial pathogens: microbiological, clínical, and epidemiological features.
Clin Microbiol Rev, 9 (1996), pp. 148-165
[2.]
M.L. Joly-Guillou, C. Brun-Buisson.
Epidemiology of Acinetobacter spp.: surveillance and management of outbreaks.
Acinetobacter: microbiology, epidemiology, infections, management, pp. 71-100
[3.]
M.L. Joly-Guillou, E. Bergogne-Bérézin, A. Philippon.
Distribution of ß-lactamases and phenotypic analysis in clinical strains of Acinetobacter calcoaceticus.
J Antimicrob Chemother, 22 (1988), pp. 597-604
[4.]
S.G.B. Amyes, H.K. Young.
Mechanism of antibiotic resistance in Acinetobacter spp. Genetics of resistance.
Acinetobacter: microbiology, epidemiology, infections, management, pp. 185-223
[5.]
G. Bou, G. Cervero, M.A. Domínguez, C. Quereda, J. Martínez-Beltran.
Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumnannii strain with a carbapenem-hydrolyzing enzyme: Highlevel carbapenem resistance is due not solely to the presence of beta-lactamases.
J Clin Microbiol, 38 (2000), pp. 3.299-3.305
[6.]
K. Bush, G.A. Jacoby, A.A. Medeiros.
A funtional classification scheme for ßlactamases and ists correlation with molecular structure.
Antimicrob Agents Chemother, 39 (1995), pp. 1.211-1.233
[7.]
G. Bou, J. Martínez-Beltran.
Cloning, nucleotide sequencing and analysis of the gene encoding an AmpC ß-Lactamase in Acinetobacter baumannii.
Antimicrob Agent Chemother, 44 (2000), pp. 428-432
[8.]
G. Bou, A. Oliver, J. Martínez Beltrán.
OXA-24, a novel class D ß-Lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain.
Antimicrob Agents Chemother, 44 (2000), pp. 1.556-1.561
[9.]
M.L. Riccio, N. Franceschini, L. Boschi, B. Caravelli, G. Cornaglia, R. Fontana, et al.
Characterization of the metallo ß-lactamase determinat of Acinetobacter baumannii AC-54/97 reveals the existance of blaIMP allelic variants carried by gene casettes of different phylogeny.
Antimicrob Agents Chemother, 44 (2000), pp. 1.229-1.235
[10.]
G. Cornaglia, M.L. Riccio, A. Mazzariol, L. Lauretti, R. Fontana, G.M. Rossolini.
Appearance of IMP-1 metallo-ß-lactamase in Europe.
Lancet, 353 (1999), pp. 899-900
[11.]
S.R. Snavely, G.R. Hodges.
The neurotoxicity of antibacterial agents.
Ann Intern Med, 101 (1984), pp. 92-104
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos